PIP antibody (HRP)
Quick Overview for PIP antibody (HRP) (ABIN1414299)
Target
See all PIP AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Predicted Reactivity
- Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from rat GCDFP15
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:100-1000
IHC-P 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- Gentamicin sulfate
-
Precaution of Use
- This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- PIP (Prolactin-Induced Protein (PIP))
-
Alternative Name
- Gcdfp15
-
Background
-
Synonyms: GCDGP 15, GCDGP-15, Gp17, GPIP4, Gross cystic disease fluid protein 15, Prolactin induced protein, Prolactin inducible protein precursor, SABP, Secretory actin binding protein.
Background: Gross cystic disease is a common premenopausal disorder in which gross cysts are the predominant pathologic lesion. It is characterized by production of a fluid secretion which accumulates in the breast cysts. Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15 kDa monomer protein, GCDFP 15. The cells within the body that produce GCDFP 15 appear to be restricted primarily to those with apocrine function. Studies have found GCDFP 15 to be a highly specific and sensitive marker for breast cancer.
Target
-